Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(9%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_1
1
9%
Ph phase_4
4
36%
Ph early_phase_1
2
18%
Ph not_applicable
1
9%
Ph phase_2
3
27%

Phase Distribution

3

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
2(18.2%)
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
3(27.3%)
Phase 4Post-market surveillance
4(36.4%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (18.2%)
Phase 11 (9.1%)
Phase 23 (27.3%)
Phase 44 (36.4%)
N/A1 (9.1%)

Trials by Status

active_not_recruiting19%
unknown327%
completed764%

Recent Activity

1 active trials
Showing 5 of 11
completedphase_2

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy

NCT03069703
completedearly_phase_1

PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

NCT07025876
active_not_recruitingphase_2

A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

NCT06708286
completedphase_1

Clinical Trial of Recombinant Pneumococcal Protein Vaccine

NCT05622942
completedphase_4

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

NCT02637583
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT03069703Phase 2

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy

Completed
NCT07025876Early Phase 1

PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Completed
NCT06708286Phase 2

A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

Active Not Recruiting
NCT05622942Phase 1

Clinical Trial of Recombinant Pneumococcal Protein Vaccine

Completed
NCT02637583Phase 4

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

Completed
NCT04974294Phase 4

PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)

Unknown
NCT04559204Phase 4

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Completed
NCT02717494Phase 2

Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women

Completed
NCT02726347Not Applicable

Pneumococcal Post-Vaccination Titers

Unknown
NCT03041051Phase 4

Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

Unknown
NCT02515240Early Phase 1

Immune Response to Pneumococcal Vaccination in HIV Infected Individuals

Completed

All 11 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
11